In two 6-week placebo-controlled medical studies (Studies 1 and 2) including 245 <a href=http://cheapzithromax.science/>antibiotics zithromax</a> people, 155 of whom were randomized to Asacol <see>Clinical Studies (14.1)], 3.2 percent of the Asacol-treated clients discontinued treatment due to unfavorable responses as contrasted to 2.2 percent of the placebo-treated people.